In the same way, the data of immunohistochemical analyses have indicated that HIF-2α was co-expressed with CD133 stem cell-like marker in GBM tissue specimens, and associated with a poor survival of glioma patients [127]. Here, PROM1 is linked to central nervous system cancer.